Skip to main content
SpringerLink
Log in

Auswirkungen einer monoklonalen Gammopathie unklarer Signifikanz

Wie steht es um Lebenserwartung und Progressionsrisiko bei der MGUS?

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  1. Kyle RA et al. N Engl J Med. 2018;378(3):241–9.

    Article  Google Scholar 

  2. Sallah S et al. Ann Oncol. 2004;15(10):1490–4.

    Article  CAS  Google Scholar 

  3. Ropper AH, Gorson KC. N Engl J Med. 1998;338(22):1601–7.

    Article  CAS  Google Scholar 

  4. Kyle RA et al. N Engl J Med. 2006;354(13):1362–9.

    Article  CAS  Google Scholar 

Literatur

  • Kyle RA et al. Long-Term Follow-up of Monoklonal Gammopathy of Undetermined Significance. N Engl J Med. 2018; 378(3):241–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Praxis Altona, Tagesklinik Struensee-Haus, Hamburg, Deutschland

    Ulrich R. Kleeberg (Hämatologisch-onkologische)

Authors
  1. Ulrich R. Kleeberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich R. Kleeberg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kleeberg, U.R. Wie steht es um Lebenserwartung und Progressionsrisiko bei der MGUS?. Info Onkol. 21, 14–15 (2018). https://doi.org/10.1007/s15004-018-6042-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6042-3

Search

Navigation